Loading…

Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda—An evaluation of the HIV test and treat strategy

Uganda adopted the HIV Test and Treat in 2016. There is paucity of data about its implementation among hospitalized patients. We aimed to determine the proportion of patients initiating anti-retroviral therapy (ART) during hospitalization, barriers and mortality outcome. In this mixed methods cohort...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2022-08, Vol.17 (8), p.e0268122-e0268122
Main Authors: Katende, Andrew, Nakiyingi, Lydia, Andia-Biraro, Irene, Katairo, Thomas, Muhumuza, Richard, Ssemata, Andrew S, Nsereko, Christopher, Semitala, Fred C, Meya, David B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c669t-c16236b4187dd42b3fb6d7702423a2e86861225e3e89d05b271383f3b60adff93
cites cdi_FETCH-LOGICAL-c669t-c16236b4187dd42b3fb6d7702423a2e86861225e3e89d05b271383f3b60adff93
container_end_page e0268122
container_issue 8
container_start_page e0268122
container_title PloS one
container_volume 17
creator Katende, Andrew
Nakiyingi, Lydia
Andia-Biraro, Irene
Katairo, Thomas
Muhumuza, Richard
Ssemata, Andrew S
Nsereko, Christopher
Semitala, Fred C
Meya, David B
description Uganda adopted the HIV Test and Treat in 2016. There is paucity of data about its implementation among hospitalized patients. We aimed to determine the proportion of patients initiating anti-retroviral therapy (ART) during hospitalization, barriers and mortality outcome. In this mixed methods cohort study, we enrolled hospitalized patients with a recent HIV diagnosis from three public hospitals in Uganda. We collected data on clinical characteristics, ART initiation and reasons for failure to initiate ART, as well as 30 day outcomes. Healthcare workers in-depth interviews were also conducted and data analyzed by sub-themes. We enrolled 234 patients; females 140/234 (59.8%), median age 34.5 years (IQR 29-42), 195/234 (83.7%) had WHO HIV stage 3 or 4, and 74/116 (63.8%) had CD4 [less than or equal to] 200 cell/[mu]L. The proportion who initiated ART during hospitalization was 123/234 (52.6%) (95% CI 46.0-59.1), of these 35/123 (28.5%) initiated ART on the same day of hospitalization, while 99/123 (80.5%) within a week of hospitalization. By 30 days 34/234 (14.5%) (95% CI 10.3-19.7) died. Patients residing [greater than or equal to] 35 kilometers from the hospital were more likely not to initiate ART during hospitalization, [aRR = 1.39, (95% CI 1.22-1.59). Inadequate patient preparation for ART initiation and advanced HIV disease were highlighted as barriers of ART initiation during hospitalization. In this high HIV prevalence setting, only half of newly diagnosed HIV patients are initiated on ART during hospitalization. Inadequate pre-ART patient preparation and advanced HIV are barriers to rapid ART initiation among hospitalized patients in public hospitals.
doi_str_mv 10.1371/journal.pone.0268122
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2704228865</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A714403218</galeid><doaj_id>oai_doaj_org_article_561750aa6f89447086d9cf11beb8d79f</doaj_id><sourcerecordid>A714403218</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-c16236b4187dd42b3fb6d7702423a2e86861225e3e89d05b271383f3b60adff93</originalsourceid><addsrcrecordid>eNqNk92K1DAYhoso7rp6B4IFQfRgxvy0-TlZGBZ1BxYW1N3TkDZJJ0unqUk6OB55C4JX6JWY7lTZyh5ID9omz_t-yZt8WfYcgiXEFL69cYPvZLvsXaeXABEGEXqQHUOO0YIggB_e-T7KnoRwA0CJGSGPsyNcclZQyo-zH6suWq-jdzvrZZvHjfay3-e2s9HKaF2Xy07lboi12-qQO5NvXOhtlK39plV-vr5e2M7oOqafPgl0F0NS51dN0slf33-uulzvZDsczJI-lRhledQh3ppHr2XMQ_Qy6mb_NHtkZBv0s-l9kl29f_f57Hxxcflhfba6WNSE8LioIUGYVAVkVKkCVdhURFEKUIGwRJoRRlIgpcaacQXKClGIGTa4IkAqYzg-yV4cfPvWBTGlGQSioECIMVImYn0glJM3ovd2K_1eOGnF7YDzjZA-2rrVoiSQlkBKYhgvCgoYUbw2EFa6Yopyk7xOp2pDtdWqTjGluGem85nObkTjdoJjDjgEyeD1ZODdlyFFJ7Y21LptZafdcFg3I7wA47pf_oPev7uJamTaQDpDl-rWo6lYUVgUACPIErW8h0qP0ltbp6tnbBqfCd7MBImJ-mts5BCCWH_6-P_s5fWcfXWH3WjZxk1w7TDeqjAHiwNYexeC1-ZvyBCIsXP-pCHGzhFT5-DfpXULjw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2704228865</pqid></control><display><type>article</type><title>Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda—An evaluation of the HIV test and treat strategy</title><source>PMC (PubMed Central)</source><source>Publicly Available Content (ProQuest)</source><creator>Katende, Andrew ; Nakiyingi, Lydia ; Andia-Biraro, Irene ; Katairo, Thomas ; Muhumuza, Richard ; Ssemata, Andrew S ; Nsereko, Christopher ; Semitala, Fred C ; Meya, David B</creator><contributor>Hsiao, Nei-yuan</contributor><creatorcontrib>Katende, Andrew ; Nakiyingi, Lydia ; Andia-Biraro, Irene ; Katairo, Thomas ; Muhumuza, Richard ; Ssemata, Andrew S ; Nsereko, Christopher ; Semitala, Fred C ; Meya, David B ; Hsiao, Nei-yuan</creatorcontrib><description>Uganda adopted the HIV Test and Treat in 2016. There is paucity of data about its implementation among hospitalized patients. We aimed to determine the proportion of patients initiating anti-retroviral therapy (ART) during hospitalization, barriers and mortality outcome. In this mixed methods cohort study, we enrolled hospitalized patients with a recent HIV diagnosis from three public hospitals in Uganda. We collected data on clinical characteristics, ART initiation and reasons for failure to initiate ART, as well as 30 day outcomes. Healthcare workers in-depth interviews were also conducted and data analyzed by sub-themes. We enrolled 234 patients; females 140/234 (59.8%), median age 34.5 years (IQR 29-42), 195/234 (83.7%) had WHO HIV stage 3 or 4, and 74/116 (63.8%) had CD4 [less than or equal to] 200 cell/[mu]L. The proportion who initiated ART during hospitalization was 123/234 (52.6%) (95% CI 46.0-59.1), of these 35/123 (28.5%) initiated ART on the same day of hospitalization, while 99/123 (80.5%) within a week of hospitalization. By 30 days 34/234 (14.5%) (95% CI 10.3-19.7) died. Patients residing [greater than or equal to] 35 kilometers from the hospital were more likely not to initiate ART during hospitalization, [aRR = 1.39, (95% CI 1.22-1.59). Inadequate patient preparation for ART initiation and advanced HIV disease were highlighted as barriers of ART initiation during hospitalization. In this high HIV prevalence setting, only half of newly diagnosed HIV patients are initiated on ART during hospitalization. Inadequate pre-ART patient preparation and advanced HIV are barriers to rapid ART initiation among hospitalized patients in public hospitals.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0268122</identifier><identifier>PMID: 35984779</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Biology and Life Sciences ; Care and treatment ; CD4 antigen ; Complications and side effects ; Data collection ; Hemoglobin ; Highly active antiretroviral therapy ; HIV ; HIV (Viruses) ; Hospitalization ; Hospitals ; Human immunodeficiency virus ; Infections ; Internal medicine ; Interviews ; Medical diagnosis ; Medical personnel ; Medical tests ; Medicine and health sciences ; Mortality ; Multivariate analysis ; Patient outcomes ; Patients ; People and Places ; Sociodemographics</subject><ispartof>PloS one, 2022-08, Vol.17 (8), p.e0268122-e0268122</ispartof><rights>COPYRIGHT 2022 Public Library of Science</rights><rights>2022 Katende et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 Katende et al 2022 Katende et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-c16236b4187dd42b3fb6d7702423a2e86861225e3e89d05b271383f3b60adff93</citedby><cites>FETCH-LOGICAL-c669t-c16236b4187dd42b3fb6d7702423a2e86861225e3e89d05b271383f3b60adff93</cites><orcidid>0000-0001-6221-8409 ; 0000-0002-2002-8911 ; 0000-0003-0060-0842</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2704228865/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2704228865?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><contributor>Hsiao, Nei-yuan</contributor><creatorcontrib>Katende, Andrew</creatorcontrib><creatorcontrib>Nakiyingi, Lydia</creatorcontrib><creatorcontrib>Andia-Biraro, Irene</creatorcontrib><creatorcontrib>Katairo, Thomas</creatorcontrib><creatorcontrib>Muhumuza, Richard</creatorcontrib><creatorcontrib>Ssemata, Andrew S</creatorcontrib><creatorcontrib>Nsereko, Christopher</creatorcontrib><creatorcontrib>Semitala, Fred C</creatorcontrib><creatorcontrib>Meya, David B</creatorcontrib><title>Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda—An evaluation of the HIV test and treat strategy</title><title>PloS one</title><description>Uganda adopted the HIV Test and Treat in 2016. There is paucity of data about its implementation among hospitalized patients. We aimed to determine the proportion of patients initiating anti-retroviral therapy (ART) during hospitalization, barriers and mortality outcome. In this mixed methods cohort study, we enrolled hospitalized patients with a recent HIV diagnosis from three public hospitals in Uganda. We collected data on clinical characteristics, ART initiation and reasons for failure to initiate ART, as well as 30 day outcomes. Healthcare workers in-depth interviews were also conducted and data analyzed by sub-themes. We enrolled 234 patients; females 140/234 (59.8%), median age 34.5 years (IQR 29-42), 195/234 (83.7%) had WHO HIV stage 3 or 4, and 74/116 (63.8%) had CD4 [less than or equal to] 200 cell/[mu]L. The proportion who initiated ART during hospitalization was 123/234 (52.6%) (95% CI 46.0-59.1), of these 35/123 (28.5%) initiated ART on the same day of hospitalization, while 99/123 (80.5%) within a week of hospitalization. By 30 days 34/234 (14.5%) (95% CI 10.3-19.7) died. Patients residing [greater than or equal to] 35 kilometers from the hospital were more likely not to initiate ART during hospitalization, [aRR = 1.39, (95% CI 1.22-1.59). Inadequate patient preparation for ART initiation and advanced HIV disease were highlighted as barriers of ART initiation during hospitalization. In this high HIV prevalence setting, only half of newly diagnosed HIV patients are initiated on ART during hospitalization. Inadequate pre-ART patient preparation and advanced HIV are barriers to rapid ART initiation among hospitalized patients in public hospitals.</description><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Biology and Life Sciences</subject><subject>Care and treatment</subject><subject>CD4 antigen</subject><subject>Complications and side effects</subject><subject>Data collection</subject><subject>Hemoglobin</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Human immunodeficiency virus</subject><subject>Infections</subject><subject>Internal medicine</subject><subject>Interviews</subject><subject>Medical diagnosis</subject><subject>Medical personnel</subject><subject>Medical tests</subject><subject>Medicine and health sciences</subject><subject>Mortality</subject><subject>Multivariate analysis</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>People and Places</subject><subject>Sociodemographics</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk92K1DAYhoso7rp6B4IFQfRgxvy0-TlZGBZ1BxYW1N3TkDZJJ0unqUk6OB55C4JX6JWY7lTZyh5ID9omz_t-yZt8WfYcgiXEFL69cYPvZLvsXaeXABEGEXqQHUOO0YIggB_e-T7KnoRwA0CJGSGPsyNcclZQyo-zH6suWq-jdzvrZZvHjfay3-e2s9HKaF2Xy07lboi12-qQO5NvXOhtlK39plV-vr5e2M7oOqafPgl0F0NS51dN0slf33-uulzvZDsczJI-lRhledQh3ppHr2XMQ_Qy6mb_NHtkZBv0s-l9kl29f_f57Hxxcflhfba6WNSE8LioIUGYVAVkVKkCVdhURFEKUIGwRJoRRlIgpcaacQXKClGIGTa4IkAqYzg-yV4cfPvWBTGlGQSioECIMVImYn0glJM3ovd2K_1eOGnF7YDzjZA-2rrVoiSQlkBKYhgvCgoYUbw2EFa6Yopyk7xOp2pDtdWqTjGluGem85nObkTjdoJjDjgEyeD1ZODdlyFFJ7Y21LptZafdcFg3I7wA47pf_oPev7uJamTaQDpDl-rWo6lYUVgUACPIErW8h0qP0ltbp6tnbBqfCd7MBImJ-mts5BCCWH_6-P_s5fWcfXWH3WjZxk1w7TDeqjAHiwNYexeC1-ZvyBCIsXP-pCHGzhFT5-DfpXULjw</recordid><startdate>20220819</startdate><enddate>20220819</enddate><creator>Katende, Andrew</creator><creator>Nakiyingi, Lydia</creator><creator>Andia-Biraro, Irene</creator><creator>Katairo, Thomas</creator><creator>Muhumuza, Richard</creator><creator>Ssemata, Andrew S</creator><creator>Nsereko, Christopher</creator><creator>Semitala, Fred C</creator><creator>Meya, David B</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6221-8409</orcidid><orcidid>https://orcid.org/0000-0002-2002-8911</orcidid><orcidid>https://orcid.org/0000-0003-0060-0842</orcidid></search><sort><creationdate>20220819</creationdate><title>Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda—An evaluation of the HIV test and treat strategy</title><author>Katende, Andrew ; Nakiyingi, Lydia ; Andia-Biraro, Irene ; Katairo, Thomas ; Muhumuza, Richard ; Ssemata, Andrew S ; Nsereko, Christopher ; Semitala, Fred C ; Meya, David B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-c16236b4187dd42b3fb6d7702423a2e86861225e3e89d05b271383f3b60adff93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Biology and Life Sciences</topic><topic>Care and treatment</topic><topic>CD4 antigen</topic><topic>Complications and side effects</topic><topic>Data collection</topic><topic>Hemoglobin</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Human immunodeficiency virus</topic><topic>Infections</topic><topic>Internal medicine</topic><topic>Interviews</topic><topic>Medical diagnosis</topic><topic>Medical personnel</topic><topic>Medical tests</topic><topic>Medicine and health sciences</topic><topic>Mortality</topic><topic>Multivariate analysis</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>People and Places</topic><topic>Sociodemographics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Katende, Andrew</creatorcontrib><creatorcontrib>Nakiyingi, Lydia</creatorcontrib><creatorcontrib>Andia-Biraro, Irene</creatorcontrib><creatorcontrib>Katairo, Thomas</creatorcontrib><creatorcontrib>Muhumuza, Richard</creatorcontrib><creatorcontrib>Ssemata, Andrew S</creatorcontrib><creatorcontrib>Nsereko, Christopher</creatorcontrib><creatorcontrib>Semitala, Fred C</creatorcontrib><creatorcontrib>Meya, David B</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints database</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Katende, Andrew</au><au>Nakiyingi, Lydia</au><au>Andia-Biraro, Irene</au><au>Katairo, Thomas</au><au>Muhumuza, Richard</au><au>Ssemata, Andrew S</au><au>Nsereko, Christopher</au><au>Semitala, Fred C</au><au>Meya, David B</au><au>Hsiao, Nei-yuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda—An evaluation of the HIV test and treat strategy</atitle><jtitle>PloS one</jtitle><date>2022-08-19</date><risdate>2022</risdate><volume>17</volume><issue>8</issue><spage>e0268122</spage><epage>e0268122</epage><pages>e0268122-e0268122</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Uganda adopted the HIV Test and Treat in 2016. There is paucity of data about its implementation among hospitalized patients. We aimed to determine the proportion of patients initiating anti-retroviral therapy (ART) during hospitalization, barriers and mortality outcome. In this mixed methods cohort study, we enrolled hospitalized patients with a recent HIV diagnosis from three public hospitals in Uganda. We collected data on clinical characteristics, ART initiation and reasons for failure to initiate ART, as well as 30 day outcomes. Healthcare workers in-depth interviews were also conducted and data analyzed by sub-themes. We enrolled 234 patients; females 140/234 (59.8%), median age 34.5 years (IQR 29-42), 195/234 (83.7%) had WHO HIV stage 3 or 4, and 74/116 (63.8%) had CD4 [less than or equal to] 200 cell/[mu]L. The proportion who initiated ART during hospitalization was 123/234 (52.6%) (95% CI 46.0-59.1), of these 35/123 (28.5%) initiated ART on the same day of hospitalization, while 99/123 (80.5%) within a week of hospitalization. By 30 days 34/234 (14.5%) (95% CI 10.3-19.7) died. Patients residing [greater than or equal to] 35 kilometers from the hospital were more likely not to initiate ART during hospitalization, [aRR = 1.39, (95% CI 1.22-1.59). Inadequate patient preparation for ART initiation and advanced HIV disease were highlighted as barriers of ART initiation during hospitalization. In this high HIV prevalence setting, only half of newly diagnosed HIV patients are initiated on ART during hospitalization. Inadequate pre-ART patient preparation and advanced HIV are barriers to rapid ART initiation among hospitalized patients in public hospitals.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>35984779</pmid><doi>10.1371/journal.pone.0268122</doi><tpages>e0268122</tpages><orcidid>https://orcid.org/0000-0001-6221-8409</orcidid><orcidid>https://orcid.org/0000-0002-2002-8911</orcidid><orcidid>https://orcid.org/0000-0003-0060-0842</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2022-08, Vol.17 (8), p.e0268122-e0268122
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2704228865
source PMC (PubMed Central); Publicly Available Content (ProQuest)
subjects Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Biology and Life Sciences
Care and treatment
CD4 antigen
Complications and side effects
Data collection
Hemoglobin
Highly active antiretroviral therapy
HIV
HIV (Viruses)
Hospitalization
Hospitals
Human immunodeficiency virus
Infections
Internal medicine
Interviews
Medical diagnosis
Medical personnel
Medical tests
Medicine and health sciences
Mortality
Multivariate analysis
Patient outcomes
Patients
People and Places
Sociodemographics
title Antiretroviral therapy initiation and outcomes of hospitalized HIV-infected patients in Uganda—An evaluation of the HIV test and treat strategy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A04%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antiretroviral%20therapy%20initiation%20and%20outcomes%20of%20hospitalized%20HIV-infected%20patients%20in%20Uganda%E2%80%94An%20evaluation%20of%20the%20HIV%20test%20and%20treat%20strategy&rft.jtitle=PloS%20one&rft.au=Katende,%20Andrew&rft.date=2022-08-19&rft.volume=17&rft.issue=8&rft.spage=e0268122&rft.epage=e0268122&rft.pages=e0268122-e0268122&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0268122&rft_dat=%3Cgale_plos_%3EA714403218%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c669t-c16236b4187dd42b3fb6d7702423a2e86861225e3e89d05b271383f3b60adff93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2704228865&rft_id=info:pmid/35984779&rft_galeid=A714403218&rfr_iscdi=true